Biocryst Pharma Inc (BCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 274,348 | 98,705 | 175,656 | 103,432 | 115,723 |
| Marketable Securities | 28,239 | 46,827 | 15,935 | 11,185 | 22,054 |
| Receivables | 8,646 | 5,422 | 3,997 | 5,642 | 22,146 |
| Inventories | 7,039 | 6,241 | 5,233 | N/A | N/A |
| TOTAL | $323,800 | $162,436 | $203,837 | $125,508 | $164,345 |
| Non-Current Assets | |||||
| PPE Net | 7,113 | 7,142 | 7,149 | 7,270 | 7,347 |
| Investments And Advances | 0 | 3,002 | 0 | 0 | 0 |
| Other Non-Current Assets | 3,802 | 3,646 | 3,720 | 3,811 | 3,590 |
| TOTAL | $10,915 | $13,790 | $10,869 | $11,081 | $10,937 |
| Total Assets | $334,715 | $176,226 | $214,706 | $136,589 | $175,282 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 19,148 | 19,056 | 14,026 | 9,020 |
| Accounts payable and accrued liabilities | 40,383 | 30,920 | 27,160 | 26,442 | 28,892 |
| Accrued Expenses | 33,942 | 30,462 | 24,843 | 20,192 | 21,365 |
| TOTAL | $105,654 | $111,777 | $102,650 | $92,699 | $92,335 |
| Non-Current Liabilities | |||||
| Long Term Debt | 244,452 | 26,893 | 31,715 | 36,513 | 41,289 |
| Deferred Revenues | 150 | 432 | 715 | 1,067 | 2,120 |
| TOTAL | $248,323 | $30,812 | $35,549 | $40,242 | $44,695 |
| Total Liabilities | $353,977 | $142,589 | $138,199 | $132,941 | $137,030 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 177,183 | 176,566 | 176,566 | 154,253 | 154,192 |
| Common Shares | 1,769 | 1,766 | 1,764 | 1,542 | 1,541 |
| Retained earnings | -1,023,442 | -962,949 | -916,834 | -878,227 | -840,628 |
| Other shareholders' equity | 3 | 9 | 3 | 14 | 39 |
| TOTAL | $-19,262 | $33,637 | $76,507 | $3,648 | $38,252 |
| Total Liabilities And Equity | $334,715 | $176,226 | $214,706 | $136,589 | $175,282 |